The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; AstraZeneca/UK; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche; Sanofi; Takeda
Research Funding - AstraZeneca/UK; Boehringer Ingelheim
Alectinib as neoadjuvant treatment in potentially resectable stage III ALK-positive NSCLC: Final analysis of ALNEO phase II trial (GOIRC-01-2020-ML42316).
 
Alessandro Leonetti
Consulting or Advisory Role - AstraZeneca; BeiGene; Novartis; Sanofi
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Pfizer; MSD; Sanofi; Takeda
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - MSD; Novartis; Roche
Other Relationship - Lilly; Novartis; Roche
 
Luca Boni
Consulting or Advisory Role - Pfizer
Patents, Royalties, Other Intellectual Property - International Patent nr. PCT/EP2012/065661
 
Letizia Gnetti
No Relationships to Disclose
 
Diego Cortinovis
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; J&J; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Giulia Pasello
No Relationships to Disclose
 
Francesca Mazzoni
Consulting or Advisory Role - Regeneron
Travel, Accommodations, Expenses - Roche
 
Alessandra Bearz
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pfizer; Regeneron; Takeda
Speakers' Bureau - Lilly; Pfizer; Roche
Research Funding - Janssen Oncology
 
Francesco Gelsomino
Consulting or Advisory Role - BMS; Novartis; Pfizer; Regeneron
Expert Testimony - AstraZeneca
 
Francesco Passiglia
Consulting or Advisory Role - Amgen; AstraZeneca/UK; MSD Oncology
Travel, Accommodations, Expenses - MSD Oncology; Roche
 
Sara Pilotto
Honoraria - AstraZeneca; BMS
Consulting or Advisory Role - Amgen; AstraZeneca; AstraZeneca/Daiichi Sankyo; Roche
Speakers' Bureau - Amgen; AstraZeneca; BMS; Lilly; Novartis; Roche; Sanofi; Takeda
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; BMS; Roche
 
Giulio Metro
No Relationships to Disclose
 
Angelo Delmonte
No Relationships to Disclose
 
Fabiana Letizia Cecere
No Relationships to Disclose
 
Federica Bertolini
No Relationships to Disclose
 
Luca Toschi
No Relationships to Disclose
 
Hector Soto Parra
No Relationships to Disclose
 
Serena Ricciardi
No Relationships to Disclose
 
Emilio Bria
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celltrion; Lilly; MSD Oncology; Pfizer; Roche; Takeda
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Michele Tognetto
No Relationships to Disclose
 
Marcello Tiseo
No Relationships to Disclose